SATURDAY, DECEMBER 14

Registration and Continental Breakfast

Stern Lobby  

Welcome and Introduction 

Ash Tewari, MBBS, MCh, FRCS (Hon.), Dsc. (Hon.)

Lifetime Achievement Award in Bladder Cancer Research / Bladder Cancer 2030 - Where Are We Going? 

Arnulf Stenzl (Prof.), MD

Introduction to Live Case

Peter Wiklund, MD, PhD

Does 3D-Guided Models for Robotic Partial Nephrectomy Have Better Outcomes?

Ketan Badani, MD, FRCS (Hon.)

Embracing Innovation: The Growing Adoption of Single-Port Partial Nephrectomy in Kidney Cancer Treatment

Simone Crivellaro, MD, MHA

The Evolving Landscape of the Robotic Nephrectomy. Multiport, Single Port, What's Next?

Senthil Nathan, MS, FRCS (Urol), FEBU, MPhil (Urol)

Advances in Kidney Cancer Ablation: Current Uses and Emerging Techniques

Leonardo Reis (Prof.), MD, MSc, PhD ,MBA Fulbright

Single Port Nephrectomy: Complications Troubleshooting. Tips & Tricks

Rene Sotelo Noguera, MD

From Hintori to 3 Xi: the Japanese Experience with Surgical Robotics

Ryoichi Shiroki (Prof.), MD, PhD

The Future of Surgery: Exploring New Robotic Platforms in the U.S.

James Porter, MD

Q&A

Single Port Surgery

FOR: Simone Crivellaro, MD, MHA; Ketan Badani, MD, FRCS

AGAINST: Jim Porter, MD; Brian Shuch, MD

Lunch / Visit Exhibits

ctDNA in Bladder Cancer

John Sfakianos, MD

State of Bladder-Sparing in Muscle-Invasive Bladder Cancer

Jason Efstathiou, MD, DPhil

Urine ctDNA Overview

Francois Audenet (Prof.), MD

Female Organ Sparing in Cystectomy 

Juhana Rautiola, MD, PhD

Q&A

Prostate Sparing Cystectomy

Doug Scherr, MD

Intravesical Therapy in BCG-Unresponsive Bladder CA

Katie Murray, DO, MS, FACS

Low Pressure Robotic Cystectomy and Considerations of Mixed Gas Pneumoperitoneum

Nikhil Vasdev, MBBS, MRCS, DSc, MCh (Urol), FRCS (Urol)

Salvage Bladder Cancer Therapy

James A. Brown, MD, MHA

Q&A

Primary RPLND vs Chemotherapy in Testes Cancer

Reza Mehrazin, MD

Robotic RPLND in Primary vs Post Chemotherapy

Peter Albers, MD

Techniques for Robot-Assisted RPLND

James Porter, MD

Trends in RPLND: Should We Be Doing More?

Aditya Bagrodia, MD

Closing Remarks

Peter Wiklund, MD, PhD